Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia

NCT00503776 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

41

Enrollment

OTHER

Sponsor class

Stopped funding became unavailable

Conditions

Dysphagia
Head and Neck Cancer
Mucositis
Xerostomia

Interventions

BEHAVIORAL: exercise intervention
DRUG: amifostine trihydrate
PROCEDURE: therapeutic dietary intervention

Sponsor

Vanderbilt-Ingram Cancer Center

Collaborators

[object Object]